REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/18/2025
Back to search
Official data from USPTO
OMBLASTYS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OMBLASTYS
ST13
US500000088320059Class
5, 42
Filing
88320059
Registration
5988020
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
02/18/2025
Trademark type
Word
Nice classes
5, 42
Filing date
02/28/2019
Registration date
02/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2020
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
CAYCEDO, CATHERINE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Y-mAbs Therapeutics, Inc
Representatives
Andrew N. Spivak MOSAIC LEGAL GROUP, PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
Class 42
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological servicesscientific researchanalysistesting in the field of antibodiesresearch and design relating thereto; industrial analysis and research services in the field of antibodies
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/15/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/15/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/05/2019
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
12/05/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/03/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/08/2019
PUBO
PUBLISHED FOR OPPOSITION
10/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/18/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/24/2019
ALIE
ASSIGNED TO LIE
08/24/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/15/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/10/2019
GNSL
LETTER OF SUSPENSION E-MAILED
05/10/2019
CNSL
SUSPENSION LETTER WRITTEN
05/10/2019
DOCK
ASSIGNED TO EXAMINER
05/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/20/2019
NWAP
NEW APPLICATION ENTERED
03/04/2019
Continuous trademark protection
Get notified about every new filing that threatens OMBLASTYS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.